AETHLON MEDICAL, INC. Restricted Stock or Unit Expense
AETHLON MEDICAL, INC. (AEMD) reported Restricted Stock or Unit Expense of $64.44 thousand for the 12-month period ending 2014-03-31, per its 10-K filed 2014-07-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2014-07-15
- AETHLON MEDICAL, INC. restricted stock or unit expense for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. restricted stock or unit expense for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. restricted stock or unit expense for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- AETHLON MEDICAL, INC. restricted stock or unit expense for the quarter ending 2013-06-30 was $64.44K, a 33.33% decline year-over-year.
- AETHLON MEDICAL, INC. restricted stock or unit expense for fiscal 2014 was $64.44K, a 83.33% decline from fiscal 2013.
- AETHLON MEDICAL, INC. restricted stock or unit expense for fiscal 2013 was $386.67K, a 0.00% change from fiscal 2012.
- AETHLON MEDICAL, INC. restricted stock or unit expense for fiscal 2012 was $386.67K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month | Restricted Stock or Unit Expense 12 month |
|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $0.00 derived: sum of 2 quarters · filed 2014-07-15 | $0.00 derived: sum of 3 quarters · filed 2014-07-15 | $64.44K 10-K · filed 2014-07-15 |
| 2013-12-31 | $0.00 10-Q · filed 2014-02-11 | $0.00 derived: sum of 2 quarters · filed 2014-02-11 | $64.44K 10-Q · filed 2014-02-11 | $161.11K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $64.44K 10-Q · filed 2013-11-14 | $161.11K derived: sum of 3 quarters · filed 2014-07-15 | $257.78K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-06-30 | $64.44K 10-Q · filed 2013-08-13 | $161.11K derived: sum of 2 quarters · filed 2014-07-15 | $257.78K derived: sum of 3 quarters · filed 2014-07-15 | $354.44K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-03-31 | $96.67K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $193.33K derived: sum of 2 quarters · filed 2014-07-15 | $290.00K derived: sum of 3 quarters · filed 2014-07-15 | $386.67K 10-K · filed 2014-07-15 |
| 2012-12-31 | $96.67K 10-Q · filed 2014-02-11 | $193.33K derived: sum of 2 quarters · filed 2014-02-11 | $290.00K 10-Q · filed 2014-02-11 | $386.67K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-09-30 | $96.67K 10-Q · filed 2013-11-14 | $193.33K 10-Q · filed 2013-11-14 | $290.00K derived: sum of 3 quarters · filed 2013-11-14 | $386.67K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $96.67K 10-Q · filed 2013-08-13 | $193.33K derived: sum of 2 quarters · filed 2013-08-13 | $290.00K derived: sum of 3 quarters · filed 2013-08-13 | $386.67K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $96.67K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-15 | $193.33K derived: sum of 2 quarters · filed 2013-07-15 | $290.00K derived: sum of 3 quarters · filed 2013-07-15 | $386.67K 10-K · filed 2013-07-15 |
| 2011-12-31 | $96.67K 10-Q · filed 2013-02-12 | $193.33K derived: sum of 2 quarters · filed 2013-02-12 | $290.00K 10-Q · filed 2013-02-12 | |
| 2011-09-30 | $96.67K 10-Q · filed 2012-11-13 | $193.33K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |